|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
AU634533B2
(en)
*
|
1989-03-21 |
1993-02-25 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Matrix metalloproteinase inhibitor peptides
|
|
US5698671A
(en)
|
1989-03-21 |
1997-12-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Metalloproteinase peptides
|
|
WO1996033735A1
(en)
|
1995-04-27 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6797492B2
(en)
|
1991-05-17 |
2004-09-28 |
Merck & Co., Inc. |
Method for reducing the immunogenicity of antibody variable domains
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
JP3017591B2
(ja)
|
1992-01-17 |
2000-03-13 |
富士薬品工業株式会社 |
抗ヒトｔｉｍｐ−２モノクローナル抗体の製法およびその利用
|
|
US6562596B1
(en)
|
1993-10-06 |
2003-05-13 |
Amgen Inc. |
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6391265B1
(en)
|
1996-08-26 |
2002-05-21 |
Biosite Diagnostics, Inc. |
Devices incorporating filters for filtering fluid samples
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
US6045899A
(en)
|
1996-12-12 |
2000-04-04 |
Usf Filtration & Separations Group, Inc. |
Highly assymetric, hydrophilic, microfiltration membranes having large pore diameters
|
|
US6319466B1
(en)
|
1997-07-16 |
2001-11-20 |
Charm Sciences, Inc. |
Test device for detecting the presence of a residue analyte in a sample
|
|
WO1999047930A1
(en)
|
1998-03-16 |
1999-09-23 |
Quidel Corporation |
Immunoassay device and method
|
|
US7214542B2
(en)
|
2003-01-30 |
2007-05-08 |
Michael Hutchinson |
Method of processing assay test results
|
|
WO2004096832A2
(en)
|
2003-04-29 |
2004-11-11 |
Children's Medical Center Corporation |
Novel antiangiogenic peptides
|
|
US20070031286A1
(en)
|
2003-08-11 |
2007-02-08 |
Kyowa Medex Co., Ltd. |
Tool for measuring object to be measured, measuring device, and measuring method
|
|
WO2006010529A1
(en)
|
2004-07-28 |
2006-02-02 |
F. Hoffmann-La Roche Ag |
Timp-2 as target/marker of beta cell failure
|
|
US7485468B2
(en)
|
2004-10-15 |
2009-02-03 |
Galapagos Bv |
Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
|
|
WO2007048102A2
(en)
|
2005-10-18 |
2007-04-26 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Angio-inhibitory peptides derived from human timp-2
|
|
NZ607703A
(en)
|
2008-10-21 |
2014-09-26 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US8900881B2
(en)
|
2008-12-30 |
2014-12-02 |
Jin Po Lee |
Quantitative analyte assay device and method
|
|
DK2488203T3
(en)
|
2009-10-16 |
2017-03-13 |
Omeros Corp |
METHODS OF TREATING DISSEMINATED INTRAVASCULAR COAGULATION BY INHIBITION OF MASP-2 DEPENDENT COMPLEMENT ACTIVATION
|
|
JP5763098B2
(ja)
|
2009-12-20 |
2015-08-12 |
アスチュート メディカル，インコーポレイテッド |
腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
|
|
PT2666872T
(pt)
|
2010-02-05 |
2016-07-08 |
Astute Medical Inc |
Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
|
|
EP2554990B1
(en)
|
2010-03-31 |
2016-08-31 |
Sekisui Medical Co., Ltd. |
Measurement method using immunochromatography, test strip for immunochromatography, and measurement reagent kit for immunochromatography
|
|
NZ605698A
(en)
|
2010-06-23 |
2015-03-27 |
Astute Medical Inc |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
RU2013107129A
(ru)
|
2010-09-30 |
2014-11-10 |
Нитто Денко Корпорейшн |
Модуляция экспрессии timp1 и timp2
|
|
CN103874923B
(zh)
|
2011-08-26 |
2016-09-14 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
ES2734494T3
(es)
|
2011-12-08 |
2019-12-10 |
Astute Medical Inc |
Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
|
|
WO2013158274A1
(en)
|
2012-04-20 |
2013-10-24 |
Academia Sinica |
ANTI-MIGE ANTIBODIES THAT BIND TO THE JUNCTION BETWEEN CH4 AND CεMX DOMAINS
|
|
EP3327037B1
(en)
|
2012-08-21 |
2019-10-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
|
TR201807542T4
(tr)
|
2013-01-17 |
2018-06-21 |
Astute Medical Inc |
Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
|
|
CN105556305A
(zh)
|
2013-06-05 |
2016-05-04 |
阿斯图特医药公司 |
用于肾损伤和肾衰竭的诊断及预后的方法和组合物
|
|
EP3617234A1
(en)
*
|
2013-08-07 |
2020-03-04 |
Astute Medical, Inc. |
Assays for timp2 having improved performance in biological samples
|
|
US9822172B2
(en)
|
2013-11-06 |
2017-11-21 |
Astute Medical, Inc. |
Assays for IGFBP7 having improved performance in biological samples
|
|
US10300108B2
(en)
|
2013-12-03 |
2019-05-28 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
KR101605421B1
(ko)
*
|
2014-03-05 |
2016-03-23 |
국립암센터 |
B 세포 림프종 세포를 특이적으로 인지하는 단일클론항체 및 이의 용도
|
|
US11243202B2
(en)
|
2015-04-09 |
2022-02-08 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
EP3465201A4
(en)
|
2016-06-06 |
2020-08-26 |
Astute Medical, Inc. |
MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
|
|
CN110352073A
(zh)
|
2016-10-28 |
2019-10-18 |
机敏医药股份有限公司 |
针对timp-2的抗体用于改善肾功能的用途
|
|
US11346846B2
(en)
|
2017-02-06 |
2022-05-31 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US11718682B2
(en)
|
2017-04-05 |
2023-08-08 |
Astute Medical, Inc. |
Assays for TIMP2 having improved performance in biological samples
|
|
WO2018208684A1
(en)
|
2017-05-07 |
2018-11-15 |
Astute Medical, Inc. |
Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy
|